Two Sigma Investments, LP Hutchmed (China) LTD Transaction History
Two Sigma Investments, LP
- $42.8 Billion
- Q1 2025
A detailed history of Two Sigma Investments, LP transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Two Sigma Investments, LP holds 47,262 shares of HCM stock, worth $728,780. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,262
Previous 58,516
19.23%
Holding current value
$728,780
Previous $843,000
15.78%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding HCM
# of Institutions
63Shares Held
6.44MCall Options Held
9.9KPut Options Held
9.6K-
Schroder Investment Management Group London, X02.84MShares$43.8 Million0.05% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1MShares$15.5 Million0.02% of portfolio
-
State Street Corp Boston, MA337KShares$5.19 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$4.86 Million0.13% of portfolio
-
M&G PLC London, X0259KShares$3.99 Million0.03% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.67B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...